CE19 - Technologies pour la santé 2021

Full-view 3D photoacoustic imaging of blood oxygenation in real-time – FULBOX

Submission summary

Photoacoustic imaging (PAI) is a biomedical imaging technique that provides optical contrasts at depth through the generation of acoustic waves with light. Handheld systems can be made for 3D navigation to image the vasculature and its oxygenation. However, these systems are impacted by limited view artifacts that hide some structures and by low contrast-to-noise when using a sparse array. Photoacoustic Fluctuation imaging (PAFI) enables to solve these two issues and we will develop further this technique towards quantitative view-full SO2 imaging. One of the challenges is to correct the spectral coloring effects due to the tissue surrounding the vessels. To this end, we will employ a highly novel multi-modal combination.
Beyond these advances concerning PAFI, this technique still suffers from its low temporal resolution. Relying on deep neural networks (DNN) image enhancement abilities, we will improve the frame rate towards the ultimate limit of SO2 images obtained from single shot multispectral images. A main challenge for DNN is to provide quantitative predictions. To address this issue, FULBOX proposes novel experimental approaches to enable real-time full-view imaging of blood oxygenation, which, coupled to state-of-the-art Ultrasound Doppler will enrich the diagnosis for several pathologies.

Project coordination

Bastien Arnal (Laboratoire Interdisciplinaire de Physique)

The author of this summary is the project coordinator, who is responsible for the content of this summary. The ANR declines any responsibility as for its contents.

Partnership

LIPHY Laboratoire Interdisciplinaire de Physique
IAB Institut pour l'Avancée des Biosciences

Help of the ANR 264,044 euros
Beginning and duration of the scientific project: September 2021 - 48 Months

Useful links

Explorez notre base de projets financés

 

 

ANR makes available its datasets on funded projects, click here to find more.

Sign up for the latest news:
Subscribe to our newsletter